Table 2.
The antimicrobial resistance pattern of the S. agalactiae isolates in the present study
| Antibiotics | No. (%) of isolates with different susceptibility pattern | No. (%) of resistant isolates in terms of centers that isolates were collected | No. (%) of resistant isolates in terms of participants’ condition | No. (%) of resistant isolates in terms of abortion | No. (%) of resistant isolates in terms of amniotic sac rupture | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resistant | Intermediate resistant | Susceptible | Shafa (n = 52) | Nime Shaban (n = 5) | Moghadam (n = 43) | Royan (n = 4) | Shahhosseini (n = 2) | Inpatient (n = 56) | Outpatient (n = 50) | Yes (n = 31) | No (n = 75) | Yes (n = 18) | No (n = 88) | |
| Penicillin | 23 (21.69) | 0 | 83 (78.3) | 16 (30.7) | 2 (40) | 5 (11.6) | 0 | 0 | 17 (30.3) | 6 (12) | 4 (12.9) | 19 (25.3) | 6 (33.3) | 17 (19.3) |
| Vancomycin | 8 (7.54) | 0 | 98 (92.45) | 2 (3.8) | 2 (40) | 2 (4.6) | 0 | 2 (50) | 2 (3.5) | 6 (12) | 2 (6.4) | 6 (8) | 0 | 8 (9) |
| Clarithromycin | 48 (45.28) | 12 (11.32) | 46 (43.39) | 22 (42.3) | 3 (60) | 19 (44.1) | 2 (50) | 2 (50) | 25 (44.6) | 23 (46) | 14 (45.1) | 34 (45.3) | 9 (50) | 39 (44.3) |
| Erythromycin | 72 (67.92) | 14 (13.2) | 20 (18.86) | 34 (65.3) | 3 (60) | 31 (72) | 2 (50) | 2 (50) | 38 (67.8) | 34 (68) | 27 (87) | 45 (60) | 14 (77.7) | 58 (65.9) |
| Clindamycin | 56 (52.83) | 4 (3.77) | 46 (43.39) | 31 (59.6) | 2 (40) | 23 (53.4) | 0 | 0 | 31 (55.3) | 25 (50) | 18 (58) | 38 (50.6) | 14 (77.7) | 42 (47.7) |
| Azithromycin | 48 (45.28) | 24 (22.64) | 34 (32.07) | 26 (50) | 2 (40) | 20 (46.5) | 0 | 0 | 26 (46.2) | 22 (44) | 14 (45.1) | 34 (45.3) | 4 (22.2) | 44 (50) |
| Gentamicin | 14 (13.2) | 0 | 92 (86.79) | 8 (15.3) | 1 (10) | 5 (11.6) | 0 | 0 | 8 (14.2) | 6 (12) | 3 (9.6) | 11 (14.6) | 2 (11.1) | 12 (13.6) |
| Kanamycin | 61 (57.54) | 0 | 45 (42.45) | 30 (57.6) | 1 (10) | 26 (60.4) | 2 (50) | 2 (50) | 29 (51.7) | 32 (64) | 19 (61.2) | 42 (56) | 6 (33.3) | 55 (62.5) |
| Levofloxacin | 72 (67.92) | 6 (5.66) | 28 (26.41) | 36 (69.2) | 1 (10) | 31 (72) | 2 (50) | 2 (50) | 39 (69.6) | 33 (66) | 21 (67.7) | 51 (68) | 16 (88.8) | 56 (63.6) |
| Ofloxacin | 83 (78.3) | 0 | 23 (21.69) | 40 (76.9) | 3 (60) | 36 (83.7) | 2 (50) | 2 (50) | 43 (76.7) | 40 (80) | 26 (83.8) | 57 (76) | 15 (83.3) | 68 (77.2) |
| Tetracycline | 100 (94.33) | 0 | 6 (5.66) | 52 (100) | 5 (100) | 37 (86) | 4 (100) | 2 (50) | 55 (98.2) | 45 (90) | 29 (93.5) | 71 (94.6) | 18 (100) | 82 (93.1 |
| Chloramphenicol | 13 (12.26) | 17 (16.03) | 76 (71.69) | 6 (11.5) | 1 (10) | 4 (9.3) | 0 | 2 (50) | 9 (16) | 4 (8) | 8 (25.8) | 5 (6.6) | 3 (16.6) | 10 (11.3) |
| Ceftriaxone | 56 (52.83) | 0 | 50 (47.16) | 32 (61.5) | 2 (40) | 22 (51.1) | 0 | 0 | 33 (58.9) | 23 (46) | 14 (45.1) | 42 (56) | 10 (55.5) | 46 (52.2) |
| Quinupristin-Dalfopristin | 64 (60.37) | 24 (22.64) | 18 (16.98) | 34 (65.3) | 5 (100) | 23 (53.4) | 0 | 2 (50) | 37 (66) | 27 (54) | 19 (61.2) | 45 (60) | 16 (88.8) | 48 (54.5) |
| Linezolid | 0 | 0 | 106 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |